l-Dopa activates histaminergic neurons

ABSTRACT: l-Dopa is the most effective treatment of early and advanced stages of Parkinson's disease (PD), but its chronic use leads to loss of efficiency and dyskinesia. This is delayed by lower dosage at early stages, made possible by additional treatment with histamine antagonists. We presen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yanovsky, Yevgenij, Li, Sha, Klyuch, Boris P, Yao, Qiaoling, Blandina, Patrizio, Passani, M Beatrice, Lin, Jian-Sheng, Haas, Helmut L, Sergeeva, Olga A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2011
Gaiak:
Neuroscience
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3082096/
https://ncbi.nlm.nih.gov/pubmed/21242252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1113/jphysiol.2010.203257
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak